For pharmacists
Clinical indications put the reason for each medicine on the prescription and the label, where pharmacist and patient can both see it. For teams working across practices, this site sets out which patients to start with, suggested wording in the Sample Directory, a simple coverage audit against an 80% standard, and the published evidence, including its limits.
The reason for the medicine. Pharmacists record the indication with the directions (FAQ 4), and FAQ 7 calls it “particularly helpful to dispensing pharmacists” in balancing a medicine’s risk and benefit for a given patient. See community pharmacy for labels and medicines use reviews.
FAQ 2 says prescriptions with clinical indications are “very popular with patients, carers, primary care staff and pharmacists”. In a 2019 UK hospital study, pharmacists called indications “helpful” or “useful” (hospitals).
They show what each medicine is for. FAQ 7 says lists of indications linked to repeat prescriptions give “a rudimentary active patient summary list”. Dr Masters’ 2013 BMJ letter proposed adding the indication at the time of issue to avoid problems of polypharmacy.
A 2016 NEJM commentary by Schiff and colleagues advocates indications-based prescribing, coupled with health information technology, as a way to improve team communication, medication reconciliation, and patient education and compliance (PubMed).
The site’s material covers four things:
In 2005 and 2006, Wycombe Primary Care Trust hosted clinical indications, including the directory, in the medicines management part of its website.
The hospital studies give different answers. A 2019 UK study found that only 4 of 64 trusts required an indication for all medicines, and its authors warn that mandatory fields “may be counterproductive”. A 2025 study in Christchurch, New Zealand, found that a compulsory field raised recording from 29% to 76%, with no change in medicine use.
That has not been shown in the work on this site. FAQ 6 says “at present there is no evidence that clinical indications assist with adherence”, and Dr Masters’ single-practice statin study calls for “prospective studies with controls”. The 2026 systematic review adds that only one of its 24 studies examined prescriptions for all medicines. See research.
Dr Masters’ FAQ 9 suggests starting with patients over 75, then over 65, then groups such as patients with diabetes or heart disease, or anyone on more than four items.
With a departure audit of repeat scripts against an 80% standard, and a destination audit at care homes.
The studies differ. The 2019 UK authors warn mandatory fields “may be counterproductive”; a 2025 New Zealand study found a compulsory field raised recording from 29% to 76%.
That has not been shown in the work on this site. Dr Masters’ single-practice statin study calls for prospective studies with controls.
Yes. Practices and medicines teams may reuse it, for example in their own formulary, as long as they credit Dr Nigel Masters and this website.
See how the indication reaches the label in a community pharmacy.
Clinical indications in community pharmacy covers the label, risk and benefit, and medicines use reviews.
Last reviewed
Get in touch
If you have a question that is not adequately answered elsewhere on the site please contact us and we will do our best to answer it.
This website uses cookies and other tracking technologies to improve your browsing experience for the following purposes: to enable basic functionality of the website, to provide a better experience on the website, to measure your interest in our products and services and to personalize marketing interactions, to deliver ads that are more relevant to you.
Contact Clinical Indications
Dr Nigel Masters, Highfield Surgery, Highfield Way, HAZLEMERE, High Wycombe, HP15 7UW
W: www.clinicalindications.co.uk
© Clinical Indications 2026. Sitemap · Privacy Policy
This site is designed and hosted by Independent Web Marketing